Hashimoto Y, Yamashita T, Koyu A, Ebihara K, Suzuki H, Kumagai M, Yoshioka O, Matsuda A
Jpn J Antibiot. 1978 Dec;31(12):837-58.
The comparative studies in the short term intermittent toxicity of pepleomycin (NK631) and bleomycin (BLM) were performed on 10 beagle dogs of 13 approximately 15 months old. Two dogs per group were injected intravenously with NK631 and BLM in doses 5.0 and 2.5 mg/kg body weight every fourth day for 11 treatment. Two dogs served as control and were injected with saline solution. In the group of 5.0 mg/kg of NK631, one dog was sacrificed on day 37 of the treatment and another one dog died on day 33 of the treatment. All the dogs of other group survived until the end of the treatment. The toxicity to the hepatic and renal damage caused by NK631 was stronger than the BLM. On the contrary, the toxicity to lung and various mucocutaneous regions was weaker than the BLM. The grade of pulmonary fibrosis of NK631 was about 1/2 and 2/3 of the BLM in dose of 5 mg/kg and 2.5 mg/kg, respectively. Other toxicological changes such as anorexia and weight loss were almost similar to the BLM.
对10只约13至15月龄的比格犬进行了培普利欧霉素(NK631)和博来霉素(BLM)短期间歇性毒性的比较研究。每组两只犬,每隔一天静脉注射剂量为5.0和2.5毫克/千克体重的NK631和BLM,共进行11次治疗。两只犬作为对照,注射生理盐水。在5.0毫克/千克NK631组中,一只犬在治疗第37天被处死,另一只犬在治疗第33天死亡。其他组的所有犬均存活至治疗结束。NK631对肝脏和肾脏损害的毒性比BLM更强。相反,其对肺和各黏膜皮肤部位的毒性比BLM弱。NK631在5毫克/千克和2.5毫克/千克剂量下的肺纤维化程度分别约为BLM的1/2和2/3。其他毒理学变化如厌食和体重减轻与BLM几乎相似。